Related Experiment Video
Updated: Jul 20, 2025

09:53
Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery
Published on: July 5, 2021
3.7K
Assessing informative tract segmentation and nTMS for pre-operative planning
Oeslle Lucena1, Jose Pedro Lavrador1, Hassna Irzan1
1King's College London, London, UK.
Journal of Neuroscience Methods
|July 31, 2023
Summary
Navigated transcranial magnetic stimulation (nTMS) motor responses can assess deep learning-based corticospinal tract (CST) segmentation uncertainty in diffuse glioma patients. This method validates segmentation accuracy and aids surgical planning.
Area of Science:
- Neuroimaging
- Neurosurgery
- Artificial Intelligence
Background:
- Deep learning (DL) excels at white matter tract segmentation in healthy subjects.
- Tract annotation is challenging in clinical data, especially in tumor patients with distorted anatomy.
- Direct cortical stimulation is invasive; navigated transcranial magnetic stimulation (nTMS) offers a non-invasive alternative for motor mapping.
Purpose of the Study:
- To evaluate nTMS motor responses for assessing DL-based corticospinal tract (CST) binary masks and uncertainty in diffuse glioma patients.
- To validate the feasibility of using nTMS as a ground truth for tract segmentation.
Main Methods:
- Utilized nTMS motor responses to assess CST binary masks and uncertainty from a DL-based segmentation method (UncSeg).
- Compared UncSeg's performance against the state-of-the-art TractSeg using overlap coefficient (OC) with nTMS response masks.
Main Results:
- CST binary masks generated by DL showed high overlap coefficients (OC) with nTMS response masks.
- A significant negative correlation was observed between segmentation uncertainty and the distance of nTMS response masks to the CST binary mask boundary.
Conclusions:
- Estimated uncertainty from UncSeg effectively measures agreement between CST binary masks and nTMS response masks.
- This approach provides a reliable, non-invasive method for validating CST segmentation in neuro-oncology patients.

